Parataxis Holdings LLC has agreed to invest nearly $18.3 million (KRW 25 billion) in South Korea’s Bridge Biotherapeutics, gaining a controlling stake and rebranding the company as Parataxis Korea. Once finalized, the deal will establish the first Bitcoin-native treasury platform in the South Korean public markets, leveraging the digital asset expertise of Parataxis Capital. Leadership […]
Source link
Ripple Concludes Pilot In Kenya Using RLUSD
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure The first field deployment of Ripple’s US-dollar...
